Analysis of Swedish patients with multiple primary melanomas and NST was negative for the CDKN2A founder mutation 113insArg, which usually explains all CDKN2A-associated familial melanoma in Sweden (Nielsen et al, 2004). Here, CDKN2A is linked to melanoma.